Latest news and articles from Age Labs

New CEO of Age Labs

André Løvestam is the new CEO of Age Labs and the board is strengthened with two new members.

New study in BMJ: Can vitamin D protect against COVID-19?

A study from our collaborators at the Oslo University Hospital on vitamin D supplementation for COVID-19 was published in the British Medical Journal today

Partnered with BioAge to investigate aging and age related diseases.

We've partnered with BioAge Labs on using longitudinal multi-omics data to investigate aging and age related diseases. The goal is to discover new drug targets and biomarkers for early disease detection.

Age Labs presenting biomarker results at ACR 2022

We’ve been accepted to present our biomarker results at ACR Convergence 2022 in Philadelphia this November. The conference attracts 15000 attendees and 4000 abstracts are submitted, so we’re delighted to have been invited to present our work in person.

Selected to pitch at Nordic Life Science Days in Malmö

In september, as 1 of 40 selected companies, we will attend NLSDays 2022 – at no cost – to pitch before a global investor community and the NLSDays audience.

Age Labs’ COVID-19 severity test being validated at Fürst, Norway’s largest medical laboratory

Age Labs’ COVID-19 severity test being validated at Fürst, Norway’s largest medical laboratory

Our paper on the epigenetic signatures of post COVID-19 patients has been published

Scientific Reports (Nature) published our paper "EWAS of post-COVID-19 patients shows methylation differences in the immune-response associated gene, IFI44L, three months after COVID-19 infection"

Results for COVID Severity Test presented at TEXGHS

Presenting two diagnostic tests at Demo Day

Age Labs presented their diagnostic test for Rheumatoid Arthritis and their test for COVID-19 severity to healthy professionals at Oslo Science Park.

Age Labs nominated as Best Healthcare Startup in the Nordic Startup Awards

We're thrilled to be nominated in the category Best HealthTech Startup of the Year at this year's Nordic Startup Awards!

Podcast: Our CEO discuss machine learning and anonymizing epigenetic data (NO)

Age Labs has worked with the Norwegian Data Protection Authority on how to anonymize epigenetic data and machine learning. Here is a 20 minute podcast discussion about this.

Our COVID-19 test explained in a simple video made by the Ministry of Health on social media

The Minister of Health, Bent Høie, visited Oslo University Hospital and Age Labs to learn about the SARS-CoV2 test in development

Identifying risk of severe COVID-19 disease - The test may play an important role

The goal is to start treatment earlier

The Minister of Public Health visits Oslo University Hospital and Age Labs to learn about the SARS-CoV-2 test in development

The corona test developed in Norway may be able to identify risk of severe disease.

Norwegian Diagnostics Firm Age Labs to Develop Epigenetics-Based Test for SARS-CoV-2

The test will identify high-risk individuals based on an epigenetic signature in a simple blood test.

Age Labs receives public research funding to develop a test predicting the severity of COVID-19 disease

Age Labs receives funding from the Research Council of Norway to develop a test to predict the severity of COVID-19 disease in collaboration with Oslo University Hospital, Bærum hospital Vestre Viken and the Norwegian Institute of Public Health

Skyfall Ventures and Aleap invest in Age Labs

We are happy to have them onboard.

Research collaboration with MERCK

MERCK and Age Labs initiate a research project on female infertility and IVF treatment

Age Labs receives public funding to develop a biological age predictor

The project is a collaboration between Fürst Medical Laboratories, the Norwegian Institute of Public Health and Oslo University Hospital.